Novo Nordisk’s next-generation weight-loss drug matches Lilly’s ...
2 days ago · Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in late ...
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
2 days ago · Last March, the F.D.A. approved Wegovy, a weight loss drug from Novo Nordisk, to reduce the risk of cardiovascular issues in people with obesity. Dani Blum is a health reporter for The Times.
US obesity rates drop for 1st time in a decade, with ... - ABC News
Dec 13, 2024 · For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...
Biden proposes weight loss drug coverage requirements for ... - NBC News
Nov 26, 2024 · The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
Diet and Weight Loss News - ScienceDaily
Dec 6, 2024 · Read weight loss articles and the latest information on dieting. Choose a diet plan based on your health and lifestyle needs. Consider the pros and cons of low carbohydrate diets, low fat diets...
Weight Loss & Obesity News - WebMD
Get the latest news on Weight Loss & Obesity management, research, treatment advancements and more from WebMD.
Weight Loss | The Latest News on Weight Loss - U.S. News & World Report
Dec 16, 2024 · Read the latest articles and commentary on weight loss at US News.
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months.
- Some results have been removed